Guandian Defense was listed on the Science and Technology Innovation Board today, witnessing the history of A-shares and becoming the first company successfully transferred to the Beijing Stock Exchange. On the first day of the transfer, Guandian Defense fell by 23.63% to close at 16.71 yuan, and the latest market value was 3.97 billion yuan. The total market value of Guandian Defense previously traded on the Beijing Stock Exchange was 5.197 billion yuan, slightly lower than the median market value of the latest science and technology innovation board stocks (5.488 billion yuan).
According to the relevant trading rules, a wide range of price limits will be set for the auction of stocks on the Science and Technology Innovation Board. Within the first 5 trading days after the listing of stocks transferred to the board, there is no price limit on the price of the stock; The drop limit is 20%.
This time, Guandian Defense will be directly transferred from the Beijing Stock Exchange to the Science and Technology Innovation Board, and no new shares will be issued. Contrary to the performance on the Beijing Stock Exchange, on the first day of the transfer, the turnover of Guandian Defense jumped from an average daily turnover of 16 million yuan to 279 million yuan, with a turnover rate of 13.69%. Before the suspension of the Beijing Stock Exchange, the share price of Guandian Defense has completed a wave of sharp rises, nearly doubling in half a year and more than three times in one year.
Guandian Defense’s announcement of transfer listing on the evening of May 24 shows that the company’s A share capital is 237.51 million shares (1.00 yuan per share), of which 112.35 million unrestricted tradable shares, accounting for about 100% of the total share capital after the transfer. 47%, and the number of shareholders of the company is 17,642. Among the top ten shareholders of Guandian Defense, there are four securities companies, namely CITIC Securities, Essence Securities, Northeast Securities and Great Wall Securities.
According to public information, Guandian Defense has been established for 18 years. Its main business is the research and development, production and sales of UAV systems and intelligent defense equipment. It is also a domestic UAV anti-drug service provider. “Little Giant” company.
In terms of performance, Guandian Defense will have a revenue of 230 million yuan in 2021 and a net profit of 72.29 million yuan attributable to the parent. The company’s performance growth in the first quarter of this year has slowed down significantly, with operating income and net profit growing at only 13% and 6.7% respectively. In the previous three years, its compound growth rate was 25.51%, and the comprehensive gross profit margin of the business exceeded 50%.
In addition, the price-earnings ratio of Guandian Defense is 72.08 times. Guandian Defense reminded that there is a risk that the company’s transfer price-earnings ratio is higher than the average level of the same industry. As of May 20, 2022, the average static price-to-earnings ratio of the “Scientific Research and Technology Services Industry” released by China Securities Index Co., Ltd. in the last month was 41.26 times.
According to Caijing.com, Guandian Defense has made several “firsts” in the capital market: the company is the “first drone anti-drug company” in the A-share market; it is the “first batch” of companies listed on the select layer in 2020; It is the “first” company to apply for transfer to the Science and Technology Innovation Board of the Stock Exchange in 2021, and it is also the “first batch” of listed companies on the Beijing Stock Exchange. 25) listed on the Science and Technology Innovation Board.
Luo Chen/Text
【Author: Luo Chen】 (Editor: Luo Chen)